BlackRock Health Sciences Trust (NYSE:BME) Shares Sold by Consolidated Portfolio Review Corp

Consolidated Portfolio Review Corp decreased its holdings in shares of BlackRock Health Sciences Trust (NYSE:BME) by 23.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 32,433 shares of the company’s stock after selling 10,141 shares during the period. Consolidated Portfolio Review Corp’s holdings in BlackRock Health Sciences Trust were worth $1,230,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in BME. Wolverine Asset Management LLC increased its holdings in BlackRock Health Sciences Trust by 42.4% in the 3rd quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock valued at $3,588,000 after purchasing an additional 25,457 shares in the last quarter. Janney Montgomery Scott LLC raised its holdings in shares of BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock valued at $1,244,000 after buying an additional 9,455 shares during the period. International Assets Investment Management LLC acquired a new position in BlackRock Health Sciences Trust during the 3rd quarter worth approximately $8,610,000. Finally, Fountainhead AM LLC purchased a new position in BlackRock Health Sciences Trust in the 3rd quarter worth approximately $204,000.

BlackRock Health Sciences Trust Stock Down 0.7 %

Shares of NYSE:BME opened at $40.72 on Friday. The company has a 50 day moving average of $39.14 and a two-hundred day moving average of $40.46. BlackRock Health Sciences Trust has a 52-week low of $36.87 and a 52-week high of $42.75.

BlackRock Health Sciences Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, February 28th. Shareholders of record on Friday, February 14th will be issued a $0.2621 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $3.15 dividend on an annualized basis and a yield of 7.72%.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.